Cellectar Biosciences, Inc (CLRB) insider trading

Every open-market stock purchase and sale by Cellectar Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $732 over the last 12 months (1 sale).
  • Last insider buy: James V Caruso (CEO), $25K, 6 months ago.

Last 12 months: insiders bought $50.5K (2 buys) and sold $732 (1 sale). Last close $1.17 on Oct 22, 2026.

Recent CLRB insider trades

DateInsiderTradeValue
Jul 8, 2026Stefan Loren (Insider)Bought (not open market)—
Jul 8, 2026Stefan Loren (Insider)Bought (not open market)—
Jul 7, 2026Frederick W Driscoll (Director)Bought (not open market)—
Jul 7, 2026Asher Chanan-Khan (Director)Bought (not open market)—
Jul 7, 2026James V Caruso (CEO)Bought (not open market)—
Jul 7, 2026Andrew Gu (Director)Bought (not open market)—
Jul 7, 2026Jarrod Longcor (COO)Bought (not open market)—
Jul 7, 2026Douglas J Swirsky (Director)Bought (not open market)—
Jul 7, 2026John Neis (Director)Bought (not open market)—
Jul 7, 2026Chad J Kolean (CFO)Bought (not open market)—
May 7, 2026James V Caruso (CEO)Bought$25K
May 7, 2026Jarrod Longcor (COO)Bought$25K
May 7, 2026James V Caruso (CEO)Bought$260
May 7, 2026Jarrod Longcor (COO)Bought$260
Dec 12, 2025John Neis (Director)Sold$732

Who's trading CLRB

Get free alerts when an insider at Cellectar Biosciences, Inc files a new trade →